As therapeutic strategies evolve, the need for more physiologically relevant assays is rapidly increasing. To meet this demand, RoukenBio has formed a strategic partnership with ScreenIn3D, combining RoukenBio’s expertise in immunology and high-content readouts with ScreenIn3D’s innovative 3D miniaturized microfluidic technology. Together, we deliver advanced, physiologically relevant assays that accelerate your drug discovery process. 

Here’s how our collaboration benefits you:

• ScreenIn3D’s Cutting-Edge Technology: ScreenIn3D’s proprietary UpScale 3D lab-on-a-chip technology miniaturizes complex assays, offering 20X higher throughput than traditional systems.
• RoukenBio’s Expertise in Immunology: Our deep knowledge of immunology allows us to design highly predictive assays using patient-derived biopsy material, closely mimicking human biological conditions.
• High-Content Readouts: RoukenBio delivers precise, high-content data through sophisticated readouts and analytics, providing comprehensive insights into immune cell activity, signal transduction, and cellular interactions.
• Faster, More Efficient Data: With ScreenIn3D’s microfluidic platform and RoukenBio’s advanced analytical capabilities, we generate high-quality, actionable data in less time, streamlining your research process.
• Tailored Co-Culture Systems: By utilising patient biopsy material in co-culture systems, we create highly relevant, physiologically accurate models for more precise drug testing.
• Scalable and Flexible Solutions: Our collaboration enables complex combination tests and modalities with unmatched scalability and precision, addressing a wide range of research needs.
• Validated, Customisable Protocols: Together, we offer a range of validated protocols to create bespoke 3D complex in vitro models tailored to your specific therapeutic goals.
   

By combining ScreenIn3D’s pioneering technology with RoukenBio’s immunology expertise and high-content readouts, we deliver state-of-the-art 3D assay solutions that provide faster, more accurate, and highly predictive results—bringing you closer to clinical success